Uniseed
Harikesh Pushpapathan is a General Partner and Managing Partner at Stoic Venture Capital, focusing on investments that advance human health and physical world applications, with a geographic emphasis on Australia and New Zealand. Since January 2022, Harikesh has been involved in several investments including Lenexa, Neurode, and Qsera. Additionally, Harikesh holds roles in various companies such as a member of the Biotech Investment Committee at Uniseed, where evaluation of biotech and healthcare opportunities from top Australian research institutions occurs, as well as an Investment Committee member at Antler and Opus Venture Capital Fund of Funds. Prior experiences include working as a Board Observer at Lenexa Medical, an Associate at Capital Capital, and an Investment Analyst at Investible and Pitch Venture Capital. Harikesh's educational background includes dual degrees in Neuroscience and Finance and in Psychology from the University of Sydney.
This person is not in any teams
Uniseed
Uniseed is Australia’s longest-running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and investment partners including a leading Australian Superannuation Fund, UniSuper. We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.